Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Jan 2026 for LISATA THERAPEUTICS, INC..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Cynthia Louise Flowers: trading record in brief
Cynthia Louise Flowers, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in G1 Therapeutics, Inc., Lisata Therapeutics, Inc. and Kadmon Holdings, Inc. In total, 12 filings cover trades dated from 8 November 2021 to 9 January 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 13 January 2026, reports a share grant in Lisata Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Cynthia Louise Flowers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
30,456 shares0Common StockSEC:0001741455-26-000003:0
15,789 shares0Common StockSEC:0001741455-25-000002:0
20,000 sharesCommon StockSEC:0000950170-24-107798:0
10,000 shares0Common StockSEC:0001562180-24-005079:0
19,480 shares0Common StockSEC:0001741455-24-000002:0
10,000 shares0Common StockSEC:0001562180-23-005271:0
20,000 shares0Common StockSEC:0001741455-23-000002:0
10,000 shares0Common StockSEC:0001562180-22-005351:0
65,430 shares0Common StockSEC:0001741455-22-000002:0
20,150 shares0Common StockSEC:0001104659-21-136411:0
10 of 10 declarations
